Chun Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Randomized Controlled Trial

Computed Tomography

Neoadjuvant Chemotherapy

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Maohui Chen, Yizhou Huang, Shuliang Zhang, Yixiong Zheng, Taidui Zeng, Chun Chen, Bin Zheng
Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial. BMJ open 14 (2) (2024)
Yizhou Huang, Maohui Chen, Zhihui Wu, Peichang Liu, Shuliang Zhang, Chun Chen, Bin Zheng
Postoperative chronic operation-related symptoms after minimally invasive lung surgery: a prospective observational protocol. BMJ open 14 (8) (2024)
Maohui Chen, Yizhou Huang, Shuliang Zhang, Yixiong Zheng, Taidui Zeng, Chun Chen, Bin Zheng
Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial. BMJ open 14 (2) (2024)
Yizhou Huang, Maohui Chen, Zhihui Wu, Peichang Liu, Shuliang Zhang, Chun Chen, Bin Zheng
Postoperative chronic operation-related symptoms after minimally invasive lung surgery: a prospective observational protocol. BMJ open 14 (8) (2024)
Yizhou Huang, Maohui Chen, Zhihui Wu, Peichang Liu, Shuliang Zhang, Chun Chen, Bin Zheng
Postoperative chronic operation-related symptoms after minimally invasive lung surgery: a prospective observational protocol. BMJ open 14 (8) (2024)
Maohui Chen, Yizhou Huang, Shuliang Zhang, Yixiong Zheng, Taidui Zeng, Chun Chen, Bin Zheng
Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial. BMJ open 14 (2) (2024)
Maohui Chen, Yizhou Huang, Shuliang Zhang, Yixiong Zheng, Taidui Zeng, Chun Chen, Bin Zheng
Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial. BMJ open 14 (2) (2024)
Mingqiang Liang, Liang Wang, Jiabin Gao, Zhiliang Duan, Jinhai Xu, Yifang Wang, Shixin Li, Bowen Wang, Chun Chen
An optimal thoracoscopic segmentectomy approach: Combined ultra-high-definition 4K endovision systems with "no-waiting" technique in S8-9 complex segmentectomy. Thoracic cancer (2023)
Mingqiang Liang, Liang Wang, Jiabin Gao, Zhiliang Duan, Jinhai Xu, Yifang Wang, Shixin Li, Bowen Wang, Chun Chen
An optimal thoracoscopic segmentectomy approach: Combined ultra-high-definition 4K endovision systems with "no-waiting" technique in S8-9 complex segmentectomy. Thoracic cancer (2023)
Jianting Du, Shuliang Zhang, Xiaodan Zhang, Zhang Yang, Songtao Xue, Guobing Xu, Bin Zheng, Chun Chen
miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expression. Thoracic cancer (2023)
Yixiong Zheng, Shuliang Zhang, Taidui Zeng, Maohui Chen, Guanglei Huang, Chi Xu, Guobing Xu, Wei Zheng, Chun Chen, Bin Zheng
A novel form of precise segmentectomy-Triumphal arch-like anatomical segmentectomy. Thoracic cancer 13 (18) (2022)
Shuliang Zhang, Feilong Guo, Hongjin Wang, Maohui Chen, Guanglei Huang, Yong Zhu, Wei Zheng, Bin Zheng, Chun Chen
Comparative analysis of electromagnetic navigation bronchoscopy versus computed tomography-guided lung puncture for the sampling of indeterminate pulmonary nodules in the middle of an anatomic lung segment: A cohort study. Thoracic cancer (2022)
Shuliang Zhang, Maohui Chen, Yizhou Huang, Guanglei Huang, Taidui Zeng, Wei Zheng, Chun Chen, Bin Zheng
"Separated" precise subsegmentectomy: Single-port thoracoscopic noncombined subsegmentectomy in one lung lobe. Thoracic cancer (2022)